Guideposts for the paths to participating in value-based healthcare models come into focus at a payment innovation summit held in Tennessee.
Although rural and disadvantaged communities are lagging behind, the shift to value-based healthcare delivery models is accelerating.
Gauging the movement of healthcare providers toward adoption of value-based contracting for their services and how to succeed in those contracts were the dominant themes for speakers at last week's National Payment Innovation Summit in Memphis, TN.
With resource-rich health systems in urban areas leading the adoption of, and investment in, value-based clinical care and payment models, healthcare providers face high financial stakes, says David Krueger, MD, MBA, executive director and CMO of Bellin-ThedaCare Healthcare Partners.
Navigating the financial perils of redesigning care while simultaneously redesigning payment models is the key question at this stage in adoption of value-based healthcare, Krueger said during a general-session presentation at the payment summit.
"How do we move both at the same time in a way that we don't get hurt?" he says of the healthcare industry's value-based-care redesign high-wire act, with 1 million patient lives in the balance just at Bellin-ThedaCare.
The Wisconsin-based health system, which experienced a measure of success in Medicare's Pioneer ACO program, has been increasing its odds for positive financial performance in value-based payment models by climbing the learning curve as quickly as possible.
It started participating in Medicare-sponsored ACO contracts in 2012, and rose to the challenge of Pioneer ACO's double-sided risk. In 2012, the health system reduced per-beneficiary-per-year spending $389 for Pioneer ACO patients, Krueger says. The performance-benchmark-beating spending reductions could not be sustained, however and the average per-beneficiary spending cut between 2012 to 2013 was only $177.
From 2012 to 2014, in the Pioneer ACO and the Medicare Shared Savings Program, Bellin-ThedaCare posted impressive results, with high quality scores, low spending levels and shared-savings payments.
Although Bellin-ThedaCare joined several other founders in pulling out of the Pioneer ACO program, Krueger praised the program's role in advancing the health system's journey toward adoption of value-payment models. "It allowed us to put a program in place… it opened the doors."
Now, more than half of Bellin-ThedaCare's 1 million patients receive care through some form of value-based payment model, including Medicare Advantage and MSSP. The shift away from fee-for-service medicine includes a fundamental examination of healthcare services and redesign of care models, he says.
In value-based payment models, healthcare providers will have to revolutionize their patient engagement strategies, Krueger says. "How do we incent them down the path? We need to know when to get out of the way."
As an advanced pilgrim in the journey toward a more value-based healthcare industry, Bellin-ThedaCare is picking partners who are moving at a similar pace and running a similar leg of the race, he says, noting the health system's participation in Appleton, WI-based, AboutHealth.
The value-oriented collaboration features eight health systems, 48 hospitals and 8,000 physicians. "Incentives are built in, right down to the front line. All patients are viewed as part of the population," Krueger says.
'Inherent Mistrust in the System'
For healthcare providers, many lessons have already been learned in the transformation from FFS medicine to value-based care models, says Darin Gordon, director of TennCare and Tennessee's deputy commissioner of health care finance administration.
A key lesson is the need for patience, the state Medicaid director says of efforts to transform care delivery and payment models simultaneously. "You can't do it overnight."
In recent years, healthcare payment and delivery reforms have been dominant elements of TennCare's administrative workload. Gordon says his experience reflects other state Medicaid leaders nationwide. "It has taken at least 50% of my time."
The necessity to pick the right partners is another key lesson learned in value-based care initiatives, he says. "Leveraging health plans has been critical."
Commercial insurance carriers have several areas of expertise that are well-suited to value-based care delivery and payment models. Areas ripe for "leveraging" include benefit and provider-network design, wellness programs, and preventive-health services, Gordon says.
With employer-sponsored insurance remaining overwhelmingly dominate in the health-coverage market, Gordon says commercial payers bring an essential partner to the value-based healthcare transformation table: large employers. The capability of large employers to provide "expertise in finding solutions has been vital," he says.
To successfully change the healthcare industry's dominant economic engine from FFS medicine to value-based payment models, a revolutionary change in mindsets will be required, Gordon says. The process of breaking down silos and linking crucial sources of information such as claims data and clinical data demands more than technological advancements in data management, he says, asserting that the process requires cooperation between longtime adversaries.
"Historically, we have not done a good job partnering with providers as much as we should. [There has been] inherent mistrust in the system."
Amy Frankowski, MD
Equipping for Value-Based Healthcare Journey
Transformational change targeted at boosting value-based clinical service delivery is an essential element of the strategic vision at Cincinatti-based Mercy Health, says Amy Frankowski, MD, senior medical director for population health and medical director of the health system's ACO, Mercy Health Select.
Mercy Health Select features 1,800 physicians and has participated in MSSP since 2012. In 2014, Mercy Health Select posted the 10th highest MSSP shared-savings payment. At $6.5 million, the 2014 shared-savings payout was the highest among Ohio-based MSSP participants.
Financial alignment with payers is an important factor for healthcare providers to achieve success in value-based payment models, Frankowski says. And long-term contracts that include robust provisions for data sharing are essential to generate positive financial results. She lists the attributes of gainful data as timeliness, relevancy, transparency, accessibility and security. "Routine data sharing could not be more important."
Building productive relationships between healthcare providers and payers is crucial to making value-based payment models function effectively, Frankowski says. "You have to have trust and you have to be at the table."
She says contracting staff should be involved at every step of the process to "avoid surprises," and lists the key factors in building strong relationships between providers and as
An early emphasis on cooperation between provider and payer clinical teams
Specificity of language during fact-finding
Contract negotiations, and sharing of data analytics capabilities
Gauging adoption speed of value-based care models
In the Friday afternoon session that closed the three-day payment innovation summit, Cristie Travis, CEO of Memphis Business Group on Health, said health systems in urban centers are leading the charge toward widespread adoption of value-based healthcare payment models.
But she said most physician practices in areas such as eastern Tennessee, western Texas and many other rural areas have yet to take their first steps toward participating in value-based payment models.
"I'm not really sure how many people are really all-in," Travis said. The disconnect" between the payment-reform summit attendees and the majority of physician practices across the country. "Most of the people out in the world don't think about this, ever!"
The middle ground of the healthcare partnership continuum is dotted with a variety of relationships that feature varying degrees of shared governance.
This article first appeared in the January/February 2016 issue of HealthLeaders magazine.
Mark Schafer, MD
The extremes of the healthcare partnership continuum are well-known and well-traveled: Narrowly focused clinical affiliations such as service contracts between hospitals and laboratories at one extreme, with mergers and acquisitions at the opposite extreme.
The middle ground of the healthcare partnership continuum is dotted with a variety of relationships that feature varying degrees of shared governance, including joint ventures, accountable care organizations, and integrated network pacts between health systems and hospitals that nearly match the intimacy of mergers and acquisitions.
Fountain Valley, California–based MemorialCare Health System, a system with 1,546 licensed beds across six hospitals and $1.9 billion in total revenue, is banking on joint ventures to help the organization maintain service revenue as medical procedures shift to outpatient settings, says Mark Schafer, MD, CEO of MemorialCare Medical Foundation, the system's physician group division that has more than 2,000 employed and affiliated physicians.
Through a joint venture established in February 2013 between the foundation and Deerfield, Illinois–based Surgical Care Affiliates, MemorialCare is operating eight ambulatory surgery centers with plans to open as many as three more. The health system also is seeking joint venture partners to split ownership of the organization's 10 imaging centers, Schafer says.
MemorialCare holds 51% ownership of the ambulatory surgery center joint venture with SCA. The joint venture consists of the newly formed surgery center company, Beach Surgical Holdings LLC, which, in turn, owns 51% of the surgical center assets. The remaining 49% of the surgical center ownership includes more than four dozen physicians. MemorialCare also wants to hold 51% ownership of the imaging centers, Schafer says.
"These types of services are moving out of the hospitals. The vast majority of these things can be done in freestanding facilities. We estimated 80% of ambulatory surgeries could be performed outside the hospital setting," he says, adding that MemorialCare is garnering a patient experience boost through providing more services closer to patients' homes at relatively low prices.
Any financial fears over a massive diversion of patient volume away from MemorialCare's hospitals appear to be unwarranted, Schafer says, noting the joint venture ambulatory surgical centers' physicians send patients to the MemorialCare facilities, including hospitals. "Initially, we thought these kinds of moves might have a negative impact on the health system, but the opposite has been true. Surgery and imaging is going to move out of the hospitals whether we want it to or not. We felt that, long-term, operating joint ventures was the right thing to do. It allows us to participate in some of the revenue stream."
MemorialCare's overall surgical volume surged 20% from the fiscal year ending June 30, 2014, to the end of the 2015 fiscal year, rising from 55,674 cases to 66,992, Schafer says. Hospital surgery volume held steady: While hospital inpatient cases fell 2%, from 18,329 to 17,921, hospital-based outpatient surgeries rose 3%, from 14,402 to 14,827. Cases at freestanding ambulatory surgery centers increased 49%, from 22,943 to 34,144.
"This is consistent with the national trend of doing less inpatient cases and our ability to do more and more on an outpatient basis," he says.
MemorialCare's joint venture philosophy features shared governance and experienced clinical partners, Schafer says. "We have a seat on the surgery center board. We work together on growth. We work together on strategy. It's much deeper than just contracting with an outside company. … It really takes a strong partner to make these affiliations work. As we look to other lines of service or opportunities, we have to make sure we find a partner with the experience and willingness to work with us."
Accountable care organizations
Partnerships developed through accountable care organizations are among the most recent innovations in the middle ground of the healthcare partnership continuum.
Katherine Schneider, MD
Radnor, Pennsylvania-based Delaware Valley ACO has participated in the Medicare Shared Savings Program since 2014, with four founding equity owners: Huntingdon Valley–based Holy Redeemer Health System, Philadelphia-based Jefferson University and Hospitals, Philadelphia-based Magee Rehabilitation Hospital, and Bryn Mawr-based Main Line Health. Doylestown Health, a small but highly integrated Pennsylvania health system centered on 237-bed Doylestown Hospital, joined the ACO in 2015.
Katherine Schneider, MD, president and CEO of Delaware Valley ACO, says the organization's equity owners "are not cookie-cutter health systems—they're all bringing different strengths to the table."
Starting in January 2014, with 33,310 Medicare beneficiaries, the ACO's 2014 MSSP spending benchmark was $394.8 million, and total spending reached $381.4 million. For the $13.4 million in shared savings that Delaware Valley generated in 2014, the ACO earned $6.6 million in shared savings payments, and Medicare saved $6.8 million, according to data collected at the Centers for Medicare & Medicaid Services.
Delaware Valley ACO is focusing its MSSP participation on primary care practices, with more than 430 participating physicians now serving about 65,000 Medicare beneficiaries. When the ACO divvies up the shared savings, there is a 30-30-40 split: 30% is allocated to the ACO for reinvestment and infrastructure financing, 30% is returned to the equity owners, and 40% is allocated to primary care practices.
As a business, Delaware Valley ACO is in its infancy, Schneider says, noting the equity owners are investing much more money in the ACO than the $6.6 million generated in 2014 shared savings payments. "The ACO's share of that distribution doesn't come near covering our current operating costs."
Delaware Valley ACO is experiencing explosive growth, which is a positive sign for recruitment of participating primary care physicians but poses a challenge to attaining financial sustainability, she says. "We're almost like a new ACO because half of the providers in 2015 are new. This is a journey we're on together. We want there to be interest. We want more physicians to come in, but it makes it harder to predict as a business model."
The ACO's equity owners and primary care physicians are committed to enduring short-term hardships to prepare for long-term success, Schneider says, noting Delaware Valley ACO is anticipating strong beneficiary and participating physician growth again this year. "The growth is because the horse has not only left the barn, it's left the state, with CMS expanding value-based payments. We've tried to message to our physicians that this is coming."
Delaware Valley ACO's 15-member governing body (with 13 voting seats) has representatives from the five equity owners and a half-dozen other members, including community stakeholders and ACO physician-practice representatives. Among the equity owners, Jefferson Health has four voting seats, Main Line Health has four, and Doylestown and Holy Redeemer each have one. The CEO of Magee Rehab, which has a 2% stake in Delaware Valley ACO, has a nonvoting seat on the governing body.
Four primary committees report up to the ACO's governing body: audit and finance, care coordination, information technology, and network development. The audit and finance committee includes CFOs from each equity owner. "Delaware Valley ACO is a separate company with representatives from its owner-members and community," says Michael Buongiorno, CPA, executive vice president and CFO at Main Line Health. He serves as chairman of Delaware Valley ACO's Audit and Finance Committee.
While Delaware Valley ACO has enjoyed a measure of early MSSP success, the organization faces challenges.
Buongiorno says Delaware Valley ACO is facing a significant challenge—a rapidly expanding new organization with an untested business model. "How much do you invest to achieve the return on investment? It's really about how much do you embed in your operations to create savings while improving the healthcare of the community."
Linking specific physicians with measurable cost savings is a daunting actuarial hurdle, Schneider says.
"As you mature as an ACO, you start to work in more performance-based initiatives. That sounds easy; but in some cases, actuarially, it's just not possible. We're not alone. … Everybody is looking at rewarding quality and rewarding population health. … If you try to pick it apart, it is more theory than mathematically valid," she says, noting that it is actuarially impossible to assign every cent of shared savings to a specific physician.
Michael Buongiorno, CPA
ACOs must develop robust data analytics capabilities to determine where cost savings are being generated before doling out physician rewards based on performance, Buongiorno says. "That is the challenge—where are the savings really coming from?"
IT investment is critical to ACO success, Schneider says. "The big one is the population health platform," which includes an integrated electronic medical record for equity owners and physician practices, data exchange capability, workflow tools tied to care coordination, and clinical systems upgrades.
Building a healthcare provider organization from scratch is a daunting task, Buongiorno says. "While this may provide a challenging endeavor, opportunities to invest in information technology and data analytics have the potential for us to improve care coordination, lower our costs, and improve the health status of the communities we serve."
Delaware Valley ACO's ownership members are taking a long-term approach to return on their investment, Schneider says. "This is like shifting the course of a battleship. … It's changing the care model."
Sole-member substitution affiliation deals
Dartmouth-Hitchcock Health, a Lebanon, New Hampshire–based health system featuring a 396-licensed-bed academic medical center, has established affiliation agreements with three relatively small hospitals in the organization's service area: 169-licensed-bed Cheshire Medical Center/Dartmouth-Hitchcock Keene in Keene, New Hampshire; 35-bed Mt. Ascutney Hospital and Health Center, a critical access hospital in Windsor, Vermont; and 25-bed New London (New Hampshire) Hospital, a critical access hospital.
"It's more than a clinical affiliation. It's really a parent-subsidiary model with the goal of improving the coordination of care for the patients we serve and enhancing value by reducing cost and improving quality. The Dartmouth-Hitchcock system has certain reserve powers over New London and the other two hospital partners that are pretty substantial," says Stephen J. LeBlanc, executive vice president for strategy and network relationships at D-H. "It's not quite a merger. They have their own boards. They have their own medical staffs."
C. Timothy Gary, JD, MBA
The legal framework for D-H's hospital-affiliate trio is sole-member substitution, he says. "The governance model is the same for all three; however, I would not describe the model as shared governance in the manner that the phrase is commonly used. Essentially, under our affiliation agreements, the organization maintains its corporate structure, but Dartmouth-Hitchcock retains specified reserve powers, such as approval of key strategic and financial decisions as well as approval of affiliate board members and CEO selection."
The recent growth of clinically integrated networks at health systems nationwide is a prime driver of hospital affiliations based on the sole-member substitution deals, says C. Timothy Gary, JD, MBA, CEO of DW Franklin Consulting Group in Nashville, a healthcare law consultancy linked to Detroit-based Dickinson Wright PLLC.
"As clinically integrated networks have become popular in the last few years, we have seen sole-member substitution agreements of this type become much more popular," Gary says. "CINs tie feeder hospitals to larger systems that have more clinical resources than the smaller facilities can sustain independently. The process essentially allows a 'sole member' to assume certain control rights on what are usually specified issues that have traditionally been controlled by the local board. This allows the center facility of the CIN, often an academic medical center, to ensure that the member facilities maintain sufficient levels of staffing and infrastructure to support the CIN agreement. These types of agreements require careful scrutiny on the part of the member facilities, especially in the control of finances."
Bruce King, MSPH, FHFMA, an employee of Mary Hitchcock Memorial Hospital, a component of D-H, who serves as president and CEO of New London Hospital, says the affiliation agreement is mutually beneficial and financially essential to the critical access hospital. "We have enjoyed a significant turnaround in 2015, and the affiliation is at least partly responsible for that."
New London Hospital finalized its D-H affiliation in October 2013. King says the affiliation's financial benefits are reflected in the 2015 fiscal year that closed June 30. The hospital posted gross revenue for 2015 at $107.7 million, which is a $9.5 million increase over 2014 gross revenue, he says. "This represents a 10% increase, of which price is 2.5%. So we experienced a 7.5% volume increase, largely attributable to added Dartmouth-Hitchcock clinical services."
Bruce King, MSPH, FHFMA
In the D-H affiliation, New London Hospital has given something to get something.
In addition to ceding the chief executive candidate search function to D-H, the hospital has granted D-H representation on its board of directors. D-H representatives account for one-third of the hospital's board, with two-thirds of the board membership drawn from the community, including the chairperson. D-H has influence over key decisions such as annual operating budgets, King says.
In return for governance concessions, New London Hospital has gained preferential access to D-H tertiary care and specialists as well as D-H–driven patient volume gains in primary care, urgent care, and expanded levels of specialty care. "We've added several clinical services," King says, noting D-H physicians in 10 specialty areas are treating patients in New London, including dermatology, oncology, orthopedics, and urology. "It means a doctor comes here to see patients as opposed to the community driving up the highway" about 25 miles to the medical center.
The affiliation has improved bed census management for both D-H and New London Hospital.
"We are often at full capacity and have to divert patients to other tertiary centers in the region. Part of the reason we are full is we are treating some low-acuity patients, too," LeBlanc says, adding that D-H hospital affiliates are helping to ensure all patients in the D-H service area have access to the right level of care at the most cost-effective setting. "We have daily care management calls every morning. We understand whether New London will be able to take our transfers or not."
New London Hospital's daily bed census has improved dramatically since the D-H affiliation, rising from fewer than 10 patients to close to 20 patients, LeBlanc says.
King notes that the D-H patient population is spread across 20 local markets and the health system functions more efficiently when low-acuity cases are treated at local facilities. "They don't want to be jammed up with services that can be provided at the local level. … They're at capacity, and we have beds available. It's very complementary and symbiotic."
As market pressures increase on healthcare providers to consolidate and integrate, there are several options to lean on partners to ease burdens and seize opportunities.
By proposing changes to performance benchmarking, Medicare officials are trying to improve the odds that cost-effective healthcare providers will earn spending-benchmark-beating payments in the Medicare Shared Savings Program.
Some big changes proposed for the Medicare Shared Savings Program are drawing a measure of praise from healthcare providers and analysts.
The biggest change, which would go into effect in January 2017, would craft financial performance benchmarking to fit local markets, says Ivy Baer, JD, MPH, senior director and regulatory counsel at the Association of American Medical Colleges, a Washington, DC-based nonprofit that represents nearly 400 teaching hospitals and health systems.
Bill Bithoney MD
Going from a national benchmark to a regional benchmark would be a "huge leap forward" for health systems, hospitals and physician practices participating in MSSP, says William "Bill" Bithoney, MD, FAAP, chief physician executive and managing director at BDO's Center for Healthcare Excellence & Innovation. "It's incredibly great."
Basing MSSP's financial performance benchmarks on national trends has been a sore point for hospitals and physicians in accountable care organizations since federal officials launched the shared savings program in 2012.
"The national benchmark can be difficult for even the most efficient healthcare providers to earn shared-savings payments in some areas of the country and "is not useful to most ACOs," Bithoney says. "It's dispiriting in high-cost markets."
Officials at the Centers for Medicare & Medicaid Services are proposing changes to MSSP's performance benchmarking that are likely to be a net positive for many ACOs, says Sarah Baumann, JD, legal analyst at Riverwoods, IL-based consultancy Wolters Kluwer.
"The rule would use county-level data when resetting benchmarks after an initial three-year agreement period, since CMS believes that counties are more stable than other geographic units and better capture regional variation in Medicare expenditures," she says.
"Rather than rebasing the benchmark by adjusting it to account for savings generated under the prior agreement period, the agency would adjust it based on regional fee-for-service expenditures. CMS thinks that adjusting benchmarks based on regional spending rather than prior performance would allow ACOs that previously enjoyed shared savings to enjoy a similar or slightly greater share of savings, and would lower benchmarks for ACOs that previously suffered losses."
More Participation, Fewer Dropouts
The increased likelihood of earning shared-savings should increase the number of hospitals and physicians participating in MSSP, Bithoney says. "You will have increased ACO participation [and] fewer dropouts. Hospitals and clinically integrated health systems are going to be more likely to join."
As of January, the MSSP roster stood at 434 ACOs, compared to 404 MSSP ACOs enrolled in the program in January 2015.
The proposed benchmarking changes are designed to reward cost-effective ACOs and to financially prod high-cost ACOs, a CMS official told me last week.
"We anticipate use of regional FFS trends could encourage the development of and continued participation by ACOs with rates of [spending] growth below that of their region. Using regional trend factors would result in relatively higher [spending] benchmarks for ACOs that are low-growth in relation to their region compared to benchmarks for ACOs that are high-growth relative to their region. Therefore, these ACOs would benefit from having a relatively higher benchmark, which would increase their chances for shared savings."
"On the other hand," the CMS representative continued, "ACOs with historically higher rates of growth above the regional average would have a relatively lower benchmark and may be discouraged from participating if they are not confident of their ability to bring their costs in line with costs in their region."
More Risk
CMS is seeking to make several other significant changes, Wolters Kluwer's Baumann says. "CMS is also continuing to encourage ACOs to assume more risk by switching from Track 1 to Tracks 2 or 3. Track 1 is a one-sided model that allows ACOs to share in savings rather than losses. Track 2 is a two-sided model that allows for more savings, but also subjects ACOs to losses. Track 3 allows for greater savings, but higher risks."
The proposed rule would allow Track 1 ACOs wishing to enter Tracks 2 or 3 to extend Track 1 participation for a fourth year, deferring benchmark rebasing, before entering the new track," she says.
"The proposed rule would limit the authority of CMS to re-open determinations of shared savings or losses to no more than four years after the date of the notification to the ACO of the initial determination, while reserving the right to reopen a payment determination at any time in the case of fraud."
Fine-tuning MSSP is going to be a daunting task for federal officials, Baer says. "It's too early to know who will or won't be helped by this; though with regional benchmarking, ACOs may be better positioned to make that determination themselves."
Thousands of hospitals and physician practices are either just contemplating or just beginning investments of money and clinical-redesign effort into building ACOs. Under the current performance benchmarking rules, many of those providers are longshots to earn shared-savings payments in the early years of an MSSP contract, Bithoney says.
"It's a real challenge to develop a care continuum," he says, noting that it takes significant investment to achieve ACO success. Care coordination, including "warm handoffs" and providing home-care support for patients who lack family members or friends as caregivers are just two elements of a successful ACO.
By the end of 2018, CMS officials are vowing to make 50% of Medicare payments for healthcare services tied to value-based care and alternative payment models such as ACOs. Volume-based FFS payments currently account for about three quarters of Medicare payments, and MSSP participation grew at less than 8% from January 2015 to this January.
The proof of whether proposed MSSP rule changes will boost participation in the ACO program will come next January, when anything less than double-digit growth will be deeply disappointing.
The 60-day period for public comments on the proposed rule changes closes March 28.
In terms of the number of human lives and costs to healthcare providers, Texas stands out among states unwilling to expand Medicaid programs to more low-income adults nationwide.
"When Texans win, they win big. And when they lose, it's spectacular."– Robert T. Kiyosaki
If Kiyosaki is right, a looming healthcare-service affordability crisis could be catastrophic to the wellbeing of the Lone Star State's poor and uninsured population.
Several hundred thousand previously uninsured Texans gained health coverage through the PPACA exchange, but about 20% of the state's 26 million people remain uninsured, says Vivian Ho, PhD, a professor of economics at Rice University and professor of medicine at Baylor School of Medicine in Houston.
Vivian Ho, PhD
"There are at least a million lives at stake," she says. "The people without insurance who can't afford healthcare services is still alarmingly high."
Ho is co-author of a pair of reports released over the past month on the affordability of healthcare services and health insurance in Texas. In one report, survey data found that 14.7% fewer Texans had problems paying for their medical bills in 2015 compared to 2013. In the other, survey data found 69.1% of uninsured Texans cite high costs as the primary reason they do not have health insurance.
Unless Texas lawmakers expand Medicaid under provisions of the Patient Protection and Affordable Care Act (PPACA), the state's modest gain in healthcare-service affordability is destined for a disastrous reversal, Ho says. "This is an extraordinary missed opportunity for people to gain access to healthcare."
There are about 1 million adult Texans who would be eligible for health coverage through Medicaid expansion, she says. A roughly equal number have health insurance coverage through the PPACA exchange, but some of them were previously insured through other means.
"What we're talking about, is an even larger expansion of coverage than we have achieved through the ACA exchange." Ho says, "This is a large group that doesn't have healthcare insurance coverage and definitely needs it." With Medicaid expansion firmly obstructed in their Republican-controlled legislature, Texas healthcare providers are facing a double whammy from Washington.
Expiring Funds
The feds are edging closer to implementingdeep cuts in the Disproportional Share Hospital (DSH) program that has offset the cost of uncompensated care over the past two decades at hospitals across the country. And the Healthcare Transformation and Quality Improvement 1115 Waiver, a five-year Medicaid program that has given Texas about $29 billion in federal funding to offset uncompensated care and to help providers pay for improvements in the delivery of healthcare services, is set to expire in the fall.
Katherine Hempstead
"A good portion of that money is going to help [low-income] adults get some kind of coverage. That's our Band-Aid," Ho says of the 1115 Waiver. "Where do people think these people are going to get care when they get sick? I'm worried about what's going to happen in three or four years."
She believes that if the waiver is not renewed, emergency rooms across Texas could be overwhelmed by poor men and women who will have nowhere else to go to seek medical attention when they need it.
This doomsday scenario is bigger than Texas, says Katherine Hempstead, health insurance program director at the Princeton, NJ-based Robert Wood Johnson Foundation:
"Texas is a little bit unique because it has a very high uninsured rate, so it has a lot of uncompensated care covered in its current Medicaid waiver. Florida is in a similar boat… But while Texas and Florida may be somewhat unique in terms of their size and their very high uninsured rates, hospitals in all states that have not yet expanded Medicaid are experiencing considerable fiscal stress.
In many of these states, hospital associations are leading expansion efforts and in many cases are willing to pay the state share through some kind of provider fee. Widespread financial distress and sometimes closings of hospitals in non-expansion states is another way to bring the message to politicians and the general public that failure to expand Medicaid can affect everyone's access to healthcare."
As of January, 31 states and the District of Columbia had expanded their Medicaid programs through provisions or waivers of the PPACA. The status of the struggle over Medicaid expansion in the remaining 19 battleground states continues.
Mounting Burdens
The collapse of the crude oil market, which is dealing a mighty blow to the Texas economy, will likely exasperate the state's healthcare affordability problems for at least the next two years, she says. "Now, we've had a loss of jobs, which means more people without health insurance, which puts an increased burden on the healthcare system."
That burden is already heavy at Southeast Texas Medical Associates (SETMA), a multi-specialty physician practice based in Beaumont.
"In anticipation of continued downward pressure on revenue, last June all SETMA partners had a 10% salary decrease," says James "Larry" Holly, MD, who serves as CEO of the physician practice.
"Our budget for this year estimates a 1% shortfall in revenue, which may be compounded if revenue streams continue to weaken. Our plan is to decrease partners' salaries further before anyone else is asked to take a decrease. Even in the face of this pressure, we paid bonuses in December 2015 to our salaried employees and we have rejected suggestions to eliminate the matching 401(k) plan funds for SETMA employees. As of yet, we have not had to turn anyone down for care, and we continue to participate in the state Medicaid program and the Affordable Care Act [health] plans."
Lives really are at stake, Holly says.
The SETMA Foundation—funded by SETMA partners—assists patients in medication purchases and co-pays for specialists not found in SETMA. These patients are treated free by SETMA. Obviously, this is a stopgap, as the Foundation can help some patients a great deal and a great deal of patients some, but we can't solve the problem… The evidence is that this intervention has been life-saving for some [patients such as] the discovery of colon cancer, which can be cured by our paying the co-pay so the patient can have a colonoscopy."
Everything really is bigger in Texas, including the shameful political partisanship over expansion of Medicaid to provide healthcare coverage to more impoverished American adults.
In the "Great Drug Pricing Debate of 2016," a semi-fictional duo goes head-to-head on whether the pricing of prescription drugs is spiraling out of control, whether price controls should be instituted, and whether drugs can be priced based on value.
Pricing practices for prescription drugs are drawing intense scrutiny from inside and outside the healthcare industry.
Healthcare payers are apoplectic over the rising costs of prescription drugs. America's Health Insurance Plans, the trade association for healthcare payers, has been blasting pharmaceutical companies over drug pricing on a nearly daily basis.
Healthcare providers also are sounding the alarm, with the American Medical Association announcing in November that it would launch an "advocacy campaign to drive solutions and help make prescription drugs more affordable."
Reginald Thump Image: TLB Designs
Drug pricing is already a hot topic in this year's presidential race, with Democratic Party contender Hillary Clinton calling for affordable drug pricing in political advertising and on her campaign's website. Her main opponent, Sen. Bernie Sanders (D, VT) has his own plan to lower prescription drug prices.
To debate the issue, I have assembled a semi-fictional duo with opposing perspectives on drug-pricing trends and their impact on the healthcare industry. The debate format gives each participant about 500 words to answer a handful of questions.
Arguing in favor of the drug-pricing practices of pharmaceutical companies is Reginald Thump, wealthy Manhattan businessman and candidate for president of the United States.
Arguing against the drug-pricing practices of pharmaceutical companies is Jennifer Campbell, analyst for healthcare cost and delivery at the National Business Group on Health.
HLM: Are prescription drug prices trending at unsustainably high levels?
Thump: This country is not as great as it used to be and certainly not as great as I could make it again. Let's face it folks, the ability to innovate is one of America's greatest strengths, and it blows my mind that my opponent and others like her want to beat up on one of the most innovative sectors of our economy.
If we want to focus on unsustainable healthcare costs, we should not be focusing on prescription drugs. Pharmacy-dispensed drugs account for about 10% of total healthcare spending, and the cost of those drugs pale in significance compared to the costs of ER visits and hospitalizations.
Drugs keep people out of the hospital, which generates cost savings for the entire healthcare industry. That's an undeniable fact that pharma's critics want to ignore.
Campbell: The trend is unsustainable.
While drug pricing and utilization both continue to surge, drug spending will increase by 6% or more annually from now until 2022, according to the Centers for Medicare & Medicaid Services. In 2014, U.S. spending on prescription drugs hit $379 billion, a third of which can be attributed to specialty drugs.
Layering on top of this growing financial burden is that these drugs are now being formulated and targeted for chronic conditions affecting much larger patient populations, a trend that will spark continued discovery and growth of specialty drugs.
Under current law, the Food and Drug Administration grants brand-name biologic drugs a 12-year exclusivity period upon approval. Such a long exclusivity period essentially removes the benefits of price competition, resulting in higher drug prices and a failure of less-costly generic versions to reach the market—all of which will continue to endanger affordable coverage options.
When there is a lack of lower cost substitutes for these steeply priced drugs, health plans and employers alike will increasingly struggle to execute drug access and cost management strategies. More and more, we are seeing that even when efficacious, low-cost generics do exist, payment incentives are not always aligned to promote their use.
Jennifer Campbell
HLM: Should there be price controls or windfall-profit taxes in the pharmaceutical sector?
Thump: Price controls would harm patients. U.S. patients have more treatment options and earlier access to medications than patients in any other country on Earth.
The new hepatitis drugs, which we should be celebrating because they cure a dreaded disease, are a great example. The doomsday predictions about these drugs have not come true. All of the patients who need these drugs have gotten these drugs. The market does work.
Campbell: We support neither approach and believe, instead, that the current pricing models are unsustainable and that manufacturers and payers should come to a consensus on pricing.
One promising approach involves manufacturers taking on risk if medications don't deliver as promised and either fail to reduce downstream costs or increase them.
HLM:What is the best way to contain rising prescription drug costs?
Thump: The costs of life-saving medications are not the problem, and the health plans should look in the mirror before they start pointing fingers at pharmaceutical companies.
The way health plans craft benefit designs contributes to increased drug prices. Some health plans require doctors to use an expensive medication when there is a cheaper alternative. Other health plans have placed generic drugs in the highest tier of their drug-pricing benefit designs with brand-name medications.
Campbell: There are a number of best practices that employers follow. In conjunction with their pharmacy benefit manager and health plan provider, employers first seek to provide employees with tools and support to guide appropriate specialty medication management.
Second, [employers seek to] create a comprehensive utilization management framework, complete with prior authorization, step therapy, quantity limit, and exclusion protocols.
Third, [they] implement a custom drug formulary that is designed based on evidence of drug safety and efficacy, and promote patient access to appropriate treatments while effectively controlling costs.
Fourth, [they] promote a more dynamic relationship between patients and their physicians and pharmacists to ensure practical treatment recommendations and compliant drug utilization behavior.
And fifth, [they] focus on site-of-care strategies and the most cost-effective distribution channels, such as specialty pharmacy chains.
HLM: Can prescription drugs be priced based on value, such as how well one drug performs clinically compared to competing drugs?
Thump: Every sector of the healthcare industry is struggling with this challenge. Singling out pharma for the sector's struggle to price prescription drugs based on value is the height of hypocrisy. I'm just saying.
Campbell: In the new value-driven healthcare system, pharma companies are feeling the pressure to demonstrate real, measurable product value. Employers have long been clamoring for more alignment between purchasers and manufacturers.
Finally, we're starting to hear more chatter around this. There are multiple efforts in the United States to make drug price determinations based on value, including the Institute for Clinical and Economic Review and DrugAbacus.
HLM: Are the costs of prescription drugs taking up too large a share of patients' total cost of care?
Thump: Again, the health plans need to take their fair share of responsibility for what is happening with the price of prescription drugs. In this country, the cost of all medications has consistently accounted for about 14% of total healthcare spending.
Patients are enduring higher out-of-pocket costs for their medications because of the way health plans are crafting benefit designs, including high deductibles. The prescription-drug share of the healthcare spend has been consistent, but the patient share of the healthcare spending burden is going up because of the way health plans are changing their benefit designs.
Campbell: The simple answer is yes, although the question is not quite that simple. As one of our forward-thinking employer members has pointed out, we need to understand the downstream costs associated with medications such as medical side effects in addition to the "value add" of the drug.
However, in general, on a per-member, per-month basis, "specialty drugs" are having an impact on patients' total cost of care. In general, increasing drug costs are driving higher costs to health plans as well as to members, both on the medical and pharmacy side.
The better question might be, "how has specialty pharmacy had an impact on the member's total medication cost share over the course of the last year or so?" To which one member responded, "It's going up, and with no end in sight."
A new Medicare payment system for physicians and other frontline providers is slated to launch in January 2019. Given the difficulties involved in crafting the new rules, federal officials have a busy three years ahead of them.
This is not going to be easy.
Last year's passage of the Medicare Access and Children's Health Insurance Program Reauthorization Act (MACRA) has set in motion a lengthy and likely arduous effort to replace Medicare's reviled Sustainable Growth Rate (SGR) formula for physician reimbursement.
Barbara L. McAneny, MD
MACRA has two essential elements: the Merit-Based Incentive Payment System (MIPS), which ties annual Medicare Physician Fee Schedule payments to value, and an incentive program to encourage physicians and other frontline healthcare workers to participate in Alternative Payment Models (APMs) that reimburse Medicare providers based on value of services rather than service volume.
The most daunting challenge facing the federal officials who are crafting the reimbursement rules for MACRA is accounting for the healthcare industry's variety of providers and the country's diverse economy, says Barbara McAneny, MD, FACP, CEO of the New Mexico Cancer Center in Albuquerque and member of the American Medical Association Board of Trustees.
"We need to figure out how we're going to take care of everybody, including the small-town doctor and the pathologist at a small community hospital. Pathologists become a commodity in the accountable-care-organization world, getting paid less and less, and then they give up," McAneny says.
While noting that almost any payment system would be better than the annual high-stakes battle in Congress over adjusting and reauthorizing SGR, the practicing oncologist says she fears officials at the Centers for Medicare & Medicaid Services (CMS) is creating a new Medicare reimbursement monstrosity. "What they should do is offer a menu of payment model options. We are facing a significant physician shortage in this country. … Therefore, we need to make sure we keep every physician as functional and financially sustainable as possible."
SGR Replacement Process Churning
CMS has taken several steps to lay the foundation for the MACRA ruling-making process.
On July 16, the Medicare Learning Network made a presentation to healthcare providers that gave a "general summary" about the MIPS and APM provisions of MACRA. In October, CMS released a Request for Information from the public about MACRA rule-making that generated more than 460 comments. Last month, CMS released a proposed Measure Development Plan (MDP) that seeks to revise and consolidate Medicare quality measures linked to physician reimbursement. The MDP, which is open to public comment through March 1, is designed to "leverage quality measure development as a key driver to further the aims of the CMS Quality Strategy: better care, smarter spending and healthier people," the document states.
The highlights of the statutory requirements of MACRA and the proposed rules to implement the SGR replacement legislation include:
Beginning in 2019, CMS will apply a positive, negative, or neutral payment adjustment to each MIPS-eligible healthcare professional based on a composite performance score across at least four performance categories: quality, resource use, clinical practice improvement activities, and meaningful use of certified electronic health record (EHR) technology.
MIPS will build upon existing quality measure sets from the Physician Quality Reporting System (PQRS), Value-based Payment Modifier (VM), and Medicare EHR Incentive Program for Eligible Professionals (EPs), commonly referred to as Meaningful Use. MACRA will sunset payment adjustments for PQRS, VM, and the EHR incentive program and establish MIPS.
In 2019 and 2020, MIPS is set to apply to payments made to physicians, physician assistants, nurse practitioners, clinical nurse specialists, and certified registered nurse anesthetists. Beginning in 2021, CMS can expand the applicability of MIPS to other healthcare professionals, including certified nurse midwives, clinical social workers, clinical psychologists, physical therapists, and speech-language pathologists.
Creation of a payment incentive program from 2019 to 2024 to encourage physicians to participate in APMs such as the Medicare Shared Saving Program.
Technical guidance and assistance for small practices and practices in health professional shortage areas (HPSAs) to ease MIPS adoption. The proposed technical guidance and assistance would apply to physicians in practices of 15 or fewer professionals, with priority given to practices located in rural areas, HPSAs, and medically underserved areas, as well as practices with low composite scores.
Proposed MACRA Rules Drawing Criticism
Particularly in rural and medically underserved areas of the country, physicians and other frontline providers are going to need more than technical assistance to survive financially under the proposed rules for MACRA, McAneny says. "We're going to need to come up with some capital to redesign the healthcare delivery system."
Linking APM participation to a 5% annual lump-sum bonus for Medicare Physician Fee Schedule payments as proposed in July's Medicare Learning Network presentation on MACRA would not compensate small physician practices adequately for the investments required to redesign the way they deliver healthcare services, she says.
For small practices, financing is often an insurmountable obstacle that blocks participation in accountable care contracting arrangements such as the Medicare Shared Saving Program, according to McAneny. "The infrastructure to build an accountable care organization costs millions of dollars. Where is a little practice going to come up with that money?"
In its response to the CMS Request for Information document released in October, the Reston, VA-based American College of Radiology offers a laundry list of proposed changes to the MIPS and APM provisions of MACRA, including a call on CMS to reduce the administrative burden on physicians. "Administrative burdens must be limited and reporting tasks streamlined so that the delivery of patient-centered care is the principal focus in all clinical settings."
The reporting requirements under MACRA are a potentially fatal flaw for the new law, McAneny says. "The administrative burden from MIPS is going to be overwhelming. … It already costs 14 cents on the dollar [for a physician] to get paid. No other industry would put up with that."
Harold Miller
MIPS may be fundamentally misguided, says Harold D. Miller, president and CEO at the Pittsburgh-based Center for Healthcare Quality and Payment Reform.
"MIPS is pay-for-performance on steroids, and there is a serious risk that it will do more harm than good. It is based on the flawed premise that physicians need 'incentives' to improve quality and control costs, despite years of evidence showing that P4P systems have little positive impact on quality or costs, and that they can have serious negative impacts on patients and physicians," he says.
"The problem with P4P systems like MIPS isn't that the incentives aren't big enough; the problem is they penalize individual physicians for costs and aspects of quality they can't control, and they don't change the underlying fee-for-service payment system so that physicians have the flexibility and resources to actually redesign care in ways that will improve quality and reduce costs in the areas they can potentially improve. MIPS is a particularly bad structure because the only way a physician can get a higher payment is if some other physician gets a lower payment, when the goal should be to have every physician receiving the resources they need to improve care so that all patients can benefit,:"; says Miller.
"In contrast," he says, "properly designed alternative payment models can create a true win-win-win: better care for patients, lower costs for payers, and physician practices that are financially viable. … They do that by fixing the problems in the underlying fee-for-service system to enable physicians to deliver care differently; and they hold physicians accountable, but only for aspects of costs and quality they can truly control."
Despite the difficulties of implementing MACRA, McAneny has a succinct response about whether she would prefer to reinstate SGR: "No. It's a new set of problems, but at least I know my practice is going to continue past January 1 of every year."
CMS officials provided several online links to information about MACRA, but they did not respond to requests for comment before this column's publication deadline.
A Q&A with the distinguished physician, who oversaw publication of the seminal "To Err is Human" report and who has prescriptions to help transform American medicine.
Even in a field sparkling with stars, Kenneth I. Shine stands out.
Shine began his career in Boston, earning his MD degree from Harvard Medical School in 1961 and training at Massachusetts General Hospital, where the cardiologist and physiologist became chief resident in medicine. Shine left the Bay State in 1969, joining the faculty at University of California, Los Angeles School of Medicine, where he was named dean in 1986. After a stint chief of the American Heart Association, Shine served as president of the Institute of Medicine from 1992 to 2002. In 1999, the nonprofit group published the earthshaking exposé on patient deaths linked to medical errors, "To Err Is Human: Building a Safer Health System." From 2003 to 2013, when he announced his (active) retirement, Shine served in several roles at the University of Texas System, including responsibility for six UT Health campuses and a budget of nearly $9 billion as executive vice chancellor for health affairs.
Kenneth Shine
I talked with Shine recently about the ongoing transformation of healthcare financing and processes, and whether healthcare delivery is any safer since the publication of "To Err is Human."
HealthLeaders Media: The shift to healthcare industry business models that emphasize value involves costly investments and complicated administrative processes. Are there sufficient financial resources to support this transformation?
Kenneth Shine: There are adequate resources. We are talking about 18% of the [U.S.] gross domestic product. That is substantially more than other Organisation of Economic Co-operation and Development countries that provide as good or better care in many areas. I don't believe the resources are the issue. The issues have to do with the organization of the system, the misalignment of financial incentives with the outcomes that we want, and the fact that our prices are the highest in the world. A couple of years ago, the average cost for a hospitalization in this country was about $16,000. That's cost—not charges. At that time in France, it was $4,700 and the length of stay was longer. The fact is that we pay far more for what we get, and we don't get the highest quality.
From my perspective, the issue is: Do we have the will to make the kind of changes that are required? This is an exciting time. Even in the absence of Obamacare, the cost of healthcare had risen to such an extent that there was an increased willingness of people to take on that cost. How do you take on that cost? You change the delivery system, you change the reimbursement system, and you make organizational changes. The resources are there … and physicians can make a good living, particularly if they are incented to keep people healthy and get paid for it.
HealthLeaders: Describe the ideal integrated health system of the emerging value-based era.
Shine: First, it does have to be value-based, where value relates the outcomes of care to the costs of care. And the health system has to be judged on the basis of whether it is providing value. Secondly, it has to be able to provide outcomes while maintaining the highest level of quality. The movement toward outcomes can only take place under circumstances in which you know how to measure quality and quality is very much a part of what the outcomes are to be measured. Thirdly, it has to be organized in such a way that it promotes health as opposed to solely treating disease. That's quite closely connected to the notion that the system has to be organized increasingly so that it is responsible for a population of patients, which is not only managed to minimize the costs of care but also organized in such a way that it promotes health.
Finally, the economic incentives, the value we pay for, have to clearly be aligned with the desirable outcomes, which include a healthy population. The incentives also need to have a process that finds the least expensive way to provide quality and takes into consideration the entire state of the individual patient's health. Such a health system has to be patient-centered: It has to be focused around the patient and the patient's needs in terms of where and how the patient gets information, gets advice, and gets treatment. And it has to be focused around the patient and the family in terms of the full spectrum of components that produce health. Only a fraction of those components are medications and procedures. Many of those components have to do with lifestyle and environment, and a truly successful health system would take those kinds of factors into consideration.
HealthLeaders: One of the areas you are working on now is supporting efforts to ease the sharing of healthcare data, such as your recent addition to the advisory board at Austin, TX-based vitaTrackr. Why do you think data sharing is one of the keys to improving healthcare?
Shine: We have a fragmented system—a fragmented industry, with a large number of large cottages. In many ways, it is a cottage industry that uses high technology but lacks organization as a real system. One of the ingredients of a real system would be a method for all of the elements of that system to effectively communicate with each other. The system I'm talking about involves physicians, it involves hospitals, it involves pharmacists, it involves everywhere where healthcare is provided. But it also, if it was a real system, would include social services, nutrition counseling, and a whole variety of elements that are critical to improve health. Having an information utility that can connect all of the different elements of the system so they can communicate with each other is essential. The patient is a key member of that system. I have talked for a long time about the concept that 21st-century care is team care, and the patient has to be a member of that team. That means we need a way to communicate between the patient and the rest of the system.
HealthLeaders: It has been 15 years since the Institute of Medicine's publication of "To Err Is Human." Is the healthcare industry safer today?
Shine: The definition of patient safety and the number of deaths from patient safety have expanded dramatically over what "To Err Is Human" described. What "To Err Is Human" focused on was the failure to carry out an action on behalf of the patient in a safe manner. It focused on medication errors, wrong-side surgery—a variety of those kinds of considerations. At that time, there was an estimate that there were between anywhere from 48,000 to 98,000 deaths. Since that time, the definition of patient safety has expanded dramatically. I am not sure the original [review] committee would have considered ventilator-associated infections as necessarily a medical error. It would have been an important complication, but it has become part of a much expanded definition of what errors are.
Many of the areas where "To Err Is Human" looked have improved substantially, and the overall system is substantially safer than it was 15 years ago. But there still is an enormous amount to do, and as the definition of deadly medical error has expanded, there are more and more things that we recognize that we have to do.
The formation of value-base payment models is the latest front in an ongoing struggle over whether to risk-adjust healthcare service reimbursement for socio-economic status.
Who pays for the medical maladies that poverty inflicts or inflames?
As the healthcare industry begins a historic shift from payment for services based on volume to payment based on value, providers serving economically disadvantaged communities are bracing for an existential financial blow.
"Anyone who serves a disadvantaged population is going to go under," says Barbara McAneny, MD, chairperson of the American Medical Association's Board of Trustees.
Based in Albuquerque, the practicing oncologist serves patients across New Mexico. McAneny's Gallup clinic treats many patients who live in poverty on Native-American reservations. "People have to decide between paying co-pays and buying food. They know what they have to do, but don't have the resources to do it," she says. Most oncology patients from the reservations have comorbidities and delay care until their health conditions have degraded to acute stages, as opposed to oncology patients from affluent Albuquerque suburbs who tend to be fundamentally healthier, McAneny says.
"The difference is not something we can control."
She says physicians who serve economically disadvantaged communities are anticipating a Dickensian nightmare as the Centers for Medicare & Medicaid Services crafts replacement payment methodologies for the long-reviled Sustained Growth Rate formula. Under SGR repeal-and-replace legislation enacted earlier this year, CMS officials are designing new value-based payment mechanisms through the Merit-Based Incentive Payment System (MIPS) and Alternative Payment Models (APMs). Unless MIPS and APMs are risk-adjusted for socio-economic status, physician practices in disadvantaged inner-city neighborhoods and rural communities face crippling financial losses, McAneny says.
"They are just hanging on to stay alive now."
With Medicare and other major payers cautious about risk-adjusting value-based payment models for socioeconomic status, patients such as Tiny Tim's character in A Christmas Carol by Charles Dickens likely will be an unwelcomed sight hobbling into a hospital or physician practice in the early phases of the shift from volume to value.
Historical Precedent The poor of 19th century London faced health-compromising living conditions similar to the hazards that the impoverished face in 21st century America, including exposure to environmental hazards, limited access to affordable healthcare services, and nutritional deficiencies.
The connection between poverty and increased risk for medical maladies is undeniable, says Otis Brawley, MD, chief medical officer of the Atlanta-based American Cancer Society and a top healthcare-disparity researcher. "The poor are more likely to live in impoverished areas. They are more likely to live down wind of factory exhaust, in smog-filled developments. There is even a correlation between living in crowded apartments with roach droppings and childhood asthma."
Consequently, "the poor are more likely to have cardiovascular disease, diabetes, cancer, asthma, and a number more acute diseases. Poverty is linked to increased risk of getting disease and being less able to deal with the consequences of the disease afterwards," he says.
But establishing and maintaining a high level of overall health is a longshot for impoverished Americans, Brawley says.
"Rather than saying poverty is causing a number of illnesses—and it is—let's focus on the fact that the middle and upper classes are more able to prevent these diseases… The poor are less likely to get healthcare services, both preventive counseling and effective treatment."
Otis Brawley, MD
"If those services are available, the poor are less likely to be able to understand and follow what can be complex instructions. There are even studies to show that the impoverished are more likely to miss appointments and fail to adhere to therapies. This can be due to [family and other] obligations as well as logistical issues such as lack of transportation.
"The thing about poverty that perhaps most drives disease is lack of education," Brawley says. "About 30% of Americans with a high-school education or lower smoke tobacco. Among college graduates, it's less than 5%. Smoking is associated with a number of chronic diseases. The children of smokers are more likely to have asthma. Obesity is a far greater issue among the impoverished versus the middleclass. This is not to say it is not an issue for the middleclass, [rather] it's disproportionately bad among the poor."
When designing MIPS and other value-based payment mechanisms, CMS and commercial health plans should take the additional costs of serving disadvantaged communities into account, Brawley argues.
"A successful healthcare system will have to recognize the additional challenges of getting care to the impoverished. These include the challenges of providing preventive care as well as treatment once a patient has been diagnosed. Some studies have suggested that the poor benefit more from patient navigation and counseling services. This involves personnel beyond the normal healthcare provider to spend time counseling the patient."
Risk-adjustment for socio-economic status should be part of value-driven payment models, says the CEO of Nashville-based DW Franklin Consulting Group, C. Timothy Gary, JD, MBA. "A value-based model can work, but it absolutely has to be adjusted for local demographics. [In disadvantaged communities,] you cannot count on the patients to have the support infrastructure in place; you cannot count on patients to follow the course of care. It's hard for them to get back to follow-up visits to their doctors. There's a shortage of physical-therapy facilities in these communities."
'An Entirely Different Mindset on the Costs'
Healthcare providers fear CMS and commercial payers will not risk-adjust value-based payment models broadly enough, including failure to account for the health-shattering impact of poverty, he says. "CMS tends to take a meat-cleaver approach when they need a scalpel… It's very similar to what we saw in the 1980s, when we moved to capitated payment rates. Providers went into deals without understanding the cost of care and the contributing factors to outlier cases… Doctors have a healthy degree of suspicion about the reimbursement models that are being crafted, and rightfully so."
Some patients, such as disabled, malnourished children like the Dickens character Tiny Tim, who grow up in grinding poverty, probably are not appropriate for participation in value-based payment models, Gary says.
"High-touch cases really don't fit into a risk-based model. There's an entirely different mindset on the costs," he says. "Higher-touch patients are a costly group that can drive costs… Providers will either eat the costs or avoid caring for that group of patients."
On Dec. 3, the Washington, DC-based National Quality Forum announced the roster of the nonprofit organization's 22-member Disparities Standing Committee. A "key focus" of the panel will be to review the findings of an ongoing two-year trial that is designed to determine whether quality metrics should be adjusted for socio-economic status and other demographic factors, according to a prepared statement from NQF. The committee is expected to make recommendations to the NQF board in 2017.
As Dickens illustrated in A Christmas Carol, accounting for the needs of the poor can be a matter of life or death, Gary says. "One way Scrooge goes, Tiny Tim lives. The other way Scrooge goes, Tiny Tim dies."
With shared interests in reducing readmission rates and associated Medicare payment penalties, hospitals and skilled nursing facilities are in the vanguard of an evolutionary movement.
This article first appeared in the December 2015 issue of HealthLeaders magazine.
The quest to deliver value for patients at health systems and hospitals has opened up a new frontier filled with golden opportunity: postacute care.
"The 30-day readmission penalty for hospitals and their SNF partners is a marker, not the endgame. The state of play right now is: How do we get to better longer-term overall care coordination?"
"There are huge benefits and very few downsides to the evolving partnerships between hospitals and postacute care settings," says Mary Naylor, PhD, RN, a gerontology professor at the University of Pennsylvania School of Nursing and director of the NewCourtland Center for Transitions and Health in Philadelphia. "It is evolutionary. It could be faster; but, nonetheless, we are not going back."
With shared interests in reducing readmission rates and associated Medicare payment penalties, hospitals and skilled nursing facilities are in the vanguard of this evolutionary movement, but the scale of change is much broader, Naylor says. "The 30-day readmission penalty for hospitals and their SNF partners is a marker, not the endgame. The state of play right now is: How do we get to better longer-term overall care coordination?"
Hospitals have faced Medicare payment penalties for patient readmissions since October 2012. SNFs and home health agencies began facing readmission payment penalties this past fall.
Mary Naylor, PhD, RN
In addition to slashing readmission rates, health systems and hospitals are banking on tighter relationships with SNFs and home care agencies to create continuity across the entire care continuum and to reduce unnecessary emergency department utilization, Naylor says. "Hospitals want to pair themselves with the best postacute care facilities."
Seizing postacute care opportunities
Whether a health system has decades of experience operating wholly owned SNFs or it is just beginning to venture into the postacute care realm, hospital executives are building new relationships with skilled nursing facilities and home health agencies.
North Shore-LIJ Health System operates wholly owned SNFs on three hospital campuses and has more than two decades of experience running postacute care facilities, says Merryl Siegel, regional executive director of postacute services for the Great Neck, New York–based organization, which has a workforce of more than 54,000. "We have lengthy experience and a well-known name in the community," she says of the health system's trio of SNFs. "The physicians trust us. We have a referral base."
"One of the key goals for us is reducing the patient leakage outside our health system."
In addition to the wholly owned SNFs, North Shore-LIJ, which will officially change its name to Northwell Health beginning in 2016, also offers services for hospice, home care, and infusions. Having a postacute care division is part of North Shore-LIJ's integrated health system strategy, which is paying off financially, Siegel says.
"One of the key goals for us is reducing the patient leakage outside our health system. Our health system is really an integrated system serving the whole care continuum. Financially, we are able to keep all of that downstream revenue beyond the acute care setting. We know where every patient is being discharged to. You can really monitor your staff, your utilization, and your length of stay."
Merryl Siegel
Over the past five years, North Shore-LIJ's leadership team has been expanding the organization's postacute care capabilities beyond the integrated health system, Siegel says. The primary focus of that effort has been creating partnerships with approximately 20 independent SNFs to meet demand for long-term care services. "We realized that we needed to partner with other facilities."
North Shore-LIJ does not have an ownership stake in the health system's off-campus SNF partners, but several metrics are monitored at the affiliates, including Medicare Nursing Home Compare star ratings, readmission and mortality rates, department of health surveys, and length of stay, she says.
"We are using the metrics to evaluate the affiliates. We are trying to move our patients to the best facilities. We collect data from all of our affiliates. As everything moves to capitation and bundled payments, it is really important that we have these relationships," Siegel says, noting length of stay at SNFs is already a crucial factor in bundled payment contracting. Length of stay will become increasingly important as the Centers for Medicare & Medicaid Services and commercial payers roll out new value-based payment models, she says. "There will be financial implications for healthcare systems and skilled nursing facilities."
Pittsburgh-based Allegheny Health Network, which has eight hospitals and 17,500 employees, does not own any SNFs, but has been boosting its postacute care capabilities over the past two years, says Brian Holzer, MD, MBA, senior vice president of home and community services.
"We are using the metrics to evaluate the affiliates. We are trying to move our patients to the best facilities."
Under the Healthcare@Home brand launched in April, AHN is developing "a postacute care model focused on home health," Holzer says, noting the service pillars of the model include hospice, home health, palliative care, home infusion, and home medical equipment and supply sales. Healthcare@Home also includes transitional care, a coordinated care model focused on discharge planning and postacute care follow-up with patients that Naylor has helped develop over the past 20 years.
Brian Holzer, MD, MBA
"The aspiration two years ago was to test a provider-driven, postacute care network," Holzer says of AHN's strategy for Healthcare@Home, noting nonproprietary partnerships with SNFs are a crucial element of the health system's grand plan for postacute care. "We do not own SNF resources. We partner with a select number of skilled nursing facilities."
AHN's SNF partners have agreed to hire highly skilled nurses to boost quality at their facilities, he says.
"We request the skilled facilities to appoint nurse practitioners to round with our patients to make sure the clinical quality meets our clinical standards. The SNFs that believe in their capabilities are welcoming this step. They see this relationship as a way to sustain their volume. It's been an incredible journey already."
While acknowledging that clinical quality at SNFs has been a weak point in the healthcare industry for decades, Holzer says establishing mutually gainful partnerships between hospitals and SNFs has the potential to fundamentally transform the care provided to older patients with multiple chronic conditions. The benefits of this transformation will be not only clinically healthier patients but also financially healthier SNFs, he says.
"We hold SNFs to standards. They know if they don't meet our standards, we can go out and find someone else who will. They know this is a path to their sustainability. We are agreeing to collaborate to create a better model of care. Beating down on SNFs and putting them out of business is not the right approach. Our approach, which provides a large amount of volume, allows them to invest in themselves and get better."
Skilled nursing facility perspective
The drive to increase collaboration between hospitals and SNFs is closely linked to the healthcare industry's shift away from fee-for-service payment models, says Lisa Thomson, chief marketing and strategy officer at White Bear Lake, Minnesota–based Pathway Health Services, a professional management and consulting organization serving clients in the long-term care and postacute care industry.
"It's a tipping point now as we move to value-based payment. It's a paradigm shift for the skilled nursing facilities," she says.
Lisa Thomson
The fee-for-service payment model has created siloed healthcare for acute care, postacute care, and home care, Thomson says, noting value-based reimbursement models such as bundled payments are encouraging all healthcare providers to focus on placing patients in the most clinically appropriate and cost-effective settings.
"With more coordination, the acute care staff has additional confidence to move the patient to the SNF setting, based on the collaboration, which required streamlined clinical systems and expected quality outcomes for the patient across all healthcare settings. The SNF feels good because they can transition the patient to a home care partner. They are all looking at the patient as a whole," she says.
In a key financial development, value-based payment models such as Medicare's bundled payments for joint replacements have resulted in an unprecedented level of data sharing, Thomson says, adding that many health systems and hospitals are gaining access to SNF billing data for the first time. "We are seeing hospitals that are looking at the data, looking at the outcomes, and identifying the SNFs that they want to work with, based on their organizational data."
As AHN has discovered with its SNF partners, skilled nursing facilities are being drawn financially to the steady patient volumes linked to closer relationships with health systems and hospitals. "SNFs will not have the higher volume of Medicare referrals with a shorter length of stay. It's a win-win clinically and a win-win financially for everyone," she says.
The Medicare payment penalty for readmissions is just the beginning of value-based care's financial impact on the postacute care sector, Thomson says. "Readmissions are the first common ground of collaboration between all of us in the care continuum. We all have to work together to keep our readmission numbers down. That's just the first of many quality measures coming down the road for the whole healthcare continuum."
Revolutionary change comes with a measure of pain, she cautions. "It forces us as organizations to determine what we are really good at and to find opportunities to do the best that we can for our patients. It will result in better outcomes, but it will be difficult. But when I see facilities embrace it, they are really energized."
Transitional care coordination
Medicare reimbursement for transitional care started in January 2014. With financial support from the nation's largest payer, transitional care has the potential to raise care coordination for older patients to new heights.
Rani Khetarpal
"Transitional care has emerged as a huge, evidence-based approach to aligning care teams with the needs and goals of patients," Naylor says. "We have an opportunity to have people's needs met in their home rather than in a more intensive setting."
The transitional care model that Naylor helped develop at UPenn has 10 essential elements, featuring highly skilled transitional care nurses who help guide patients through an entire acute episode of care, from hospital admission to home care. Other elements of UPenn's transitional care model include in-hospital assessments and evidence-based plans of care, TCNs conducting regular home visits, engagement of patients and family caregivers, and a holistic approach to patient care that not only addresses the acute care episode but also other factors impacting a patient's health such as home safety and medication management.
"Medicare pays for 30 days of clinical transitional care postdischarge from a hospital or skilled nursing facility," says Rani Khetarpal, CEO of Global Transitional Care, a Newport Beach, California–based third-party specialty group provider organization dedicated to providing comprehensive transitional care. "We know what the needs are. We know the situation at home. And we can talk about all of that with the patient and all of the members of the patient's care team. It provides for a seamless transition from the hospital or the SNF to the home."
The organization is only working with California patients this year, but it has applied to CMS for the ability to operate in all 50 states.
"As a provider, we now have the ability to make decisions on behalf of the patient. However, we prefer to collaborate with the patient's physician care team on any medical decisions," Khetarpal says. "Patients can self-refer to our care. We do not require a physician's order to provide services. Our focus is the patient. We are independent. That's the beauty of being a third-party provider."
GTC's third-party status distinguishes the organization from AHN and other health systems that are offering transitional care services, she says. "Health systems with transitional care are only managing their own patients. However, the capacity to provide transitional care to all their patients is somewhat limited due to the lack of necessary resources. But I don't want to disparage any healthcare provider that is offering transitional care. Any transitional care program is fantastic. There are so many patients who need this service. We cannot serve all of them."
Naylor says she is pleased with the rise of transitional care and the decline of silo-based approaches to healthcare service delivery, particularly for older patients.
"It is tremendously exciting," she says. "We cannot ignore that major drivers in this change are the patients and their family caregivers. They have been watching. They are saying, 'This cannot be the way we treat our most treasured citizens.' "
"What has emerged, more and more, are atypical relationships that aren't focused on ownership; they're focused on leveraging the strength of our partners," says one senior executive.
This article appears in the October 2015 issue of HealthLeaders magazine.
For health systems across the country, clinical affiliations have emerged as an attractive alternative to mergers and acquisitions, which come with ownership stakes attached.
Most health system clinical affiliations feature relationships with local medical service providers that help the hospital group cost-effectively fill gaps in the organization's care continuum, such as partnerships with independent urgent care centers. Junior partners gain several financially related benefits from health system clinical affiliations, including service volume growth and the ability to maintain most, if not all, of their independence.
"There is a tremendous amount of potential from partnerships," says Thomas Blincoe, executive director of outreach for The Ohio State University Wexner Medical Center and executive director of Ohio State Health Network, a regional affiliation of 15 community hospitals centered around Ohio State University Wexner Medical Center in Columbus. "What has emerged, more and more, are atypical relationships that aren't focused on ownership; they're focused on leveraging the strength of our partners."
For the fiscal year ending June 30, 2015, OSU Wexner Medical Center posted total gross revenues of $7.3 billion.